EPIC Study Team. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015 Jul 30;373(5):415-27. \[[PMC free article: PMC4728150](/pmc/articles/PMC4728150/)\] \[[PubMed: 26172429](https://pubmed.ncbi.nlm.nih.gov/26172429)\] 9. Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG. Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med. 2019 Feb;45(2):159-171. \[[PMC free article: PMC7094947](/pmc/articles/PMC7094947/)\] \[[PubMed: 30706119](https://pubmed.ncbi.nlm.nih.gov/30706119)\] 10. Pickens CI, Wunderink RG. Principles and Practice of Antibiotic Stewardship in the ICU. Chest. 2019 Jul;156(1):163-171. \[[PMC free article: PMC7118241](/pmc/articles/PMC7118241/)\] \[[PubMed: 30689983](https://pubmed.ncbi.nlm.nih.gov/30689983)\] 11. Nuttall JJC. Current antimicrobial management of community-acquired pneumonia in HIV-infected children. Expert Opin Pharmacother. 2019 Apr;20(5):595-608. \[[PubMed: 30664362](https://pubmed.ncbi.nlm.nih.gov/30664362)\] 12. Froes F, Pereira JG, Póvoa P. Outpatient management of community-acquired pneumonia. Curr Opin Pulm Med. 2019 May;25(3):249-256. \[[PubMed: 30585861](https://pubmed.ncbi.nlm.nih.gov/30585861)\] 13. Mi X, Li W, Zhang L, Li J, Zeng L, Huang L, Chen L, Song H, Huang Z, Lin M. The drug use to treat community-acquired pneumonia in children: A cross-sectional study in China. Medicine (Baltimore). 2018 Nov;97(46):e13224. \[[PMC free article: PMC6257659](/pmc/articles/PMC6257659/)\] \[[PubMed: 30431600](https://pubmed.ncbi.nlm.nih.gov/30431600)\] 14. Hagel S, Moeser A, Pletz MW. [Management of community acquired pneumonia]. MMW Fortschr Med. 2018 Nov;160(19):52-61. \[[PubMed: 30406515](https://pubmed.ncbi.nlm.nih.gov/30406515)\] 15. Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, Davis-Karim A, Umberger R, Anzueto A, Sriram P, Lan C, Restrepo MI, Guardiola JJ, Buck T, Johnson DP, Suffredini A, Bell WA, Lin J, Zhao L, Uyeda L, Nielsen L, Huang GD., ESCAPe Study Group. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022 Aug;48(8):1009-1023. \[[PMC free article: PMC9208259](/pmc/articles/PMC9208259/)\] \[[PubMed: 35723686](https://pubmed.ncbi.nlm.nih.gov/35723686)\] 16. Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, Reignier J, Heming N, Plantefève G, Souweine B, Voiriot G, Colin G, Frat JP, Mira JP, Barbarot N, François B, Louis G, Gibot S, Guitton C, Giacardi C, Hraiech S, Vimeux S, L'Her E, Faure H, Herbrecht JE, Bouisse C, Joret A, Terzi N, Gacouin A, Quentin C, Jourdain M, Leclerc M, Coffre C, Bourgoin H, Lengellé C, Caille-Fénérol C, Giraudeau B, Le Gouge A., CRICS-TriGGERSep Network. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023 May 25;388(21):1931-1941. \[[PubMed: 36942789](https://pubmed.ncbi.nlm.nih.gov/36942789)\] 17. Bergmann F, Pracher L, Sawodny R, Blaschke A, Gelbenegger G, Radtke C, Zeitlinger M, Jorda A. Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials. Clin Infect Dis. 2023 Dec 15;77(12):1704-1713. \[[PubMed: 37876267](https://pubmed.ncbi.nlm.nih.gov/37876267)\] 18. Peng B, Li J, Chen M, Yang